Consensus Ridgepost Capital, Inc

Stocks

RPC

US69376K1060

Investment Management & Fund Operators

Market Closed - NYSE 00:00:02 07/11/2026 +03			5-day change	1st Jan Change
9.700 ^USD	-0.82%		+5.21%	-1.12%

11-04	Ridgepost Capital, Inc, Q3 2026 Earnings Call, Nov 04, 2026
11-04	Earnings Flash (RPC) Ridgepost Capital Posts Q3 Revenue $88.9M, vs. FactSet Est of $97.4M	MT

Evolution of the Average Target: Ridgepost Capital, Inc

Evolution of the Target Price: Ridgepost Capital, Inc

Changes in Analyst Recommendations: Ridgepost Capital, Inc

a4642b49fe8.SkjlDfKyA0tPd8PCJOq4JwLqhwqBTY8cy3M3c9rCjAY.ehGyZZ72dAx6GayydLP6cFev7XCsPO53mTl1A4WHtVYfOYdjkPk6PCUzjg~057081faff75dd138241d401d78b080c

Analysts' recommendations: Ridgepost Capital, Inc

08-27	Oppenheimer Adjusts Price Target on Ridgepost Capital to $15 From $16, Keeps Outperform Rating	MT
08-06	Oppenheimer Adjusts PT on Ridgepost Capital to $16 From $17, Maintains Outperform Rating	MT
04-13	Oppenheimer Adjusts Ridgepost Capital Price Target to $16 From $24, Maintains Outperform Rating	MT
15/05/25	Oppenheimer Lifts Price Target on P10 to $20 From $19, Keeps Outperform Rating	MT
12/05/25	Oppenheimer Adjusts P10 Price Target to $19 From $18, Maintains Outperform Rating	MT
07/01/25	JPMorgan Upgrades P10 to Overweight From Neutral, Adjusts Price Target to $15 From $14	MT
12/12/24	Oppenheimer Adjusts Price Target on P10 to $21 From $17, Maintains Outperform Rating	MT
13/11/24	UBS Raises Price Target on P10 to $13 From $12, Maintains Neutral Rating	MT
22/10/24	UBS Adjusts P10 Price Target to $12 From $10.50, Maintains Neutral Rating	MT
16/10/24	Oppenheimer Adjusts P10 Price Target to $16 From $13, Maintains Outperform Rating	MT
21/08/24	UBS Downgrades P10 to Neutral From Buy, Raises Price Target to $10.50 From $10	MT
12/08/24	P10 Outperformed Expectations in Q2 With Strong Fees, Shares Undervalued, Oppenheimer Says	MT
08/07/24	Oppenheimer Adjusts Price Target on P10 to $13 From $12, Maintains Outperform Rating	MT
12/04/24	Oppenheimer Adjusts P10 Price Target to $12 From $11, Maintains Outperform Rating	MT
04/03/24	Barclays Adjusts Price Target on P10 to $9.50 From $14, Maintains Overweight Rating	MT
04/03/24	Morgan Stanley Downgrades P10 to Equalweight From Overweight, Price Target is $9	MT
04/03/24	Oppenheimer Adjusts P10 Price Target to $11 From $17, Maintains Outperform Rating	MT
01/03/24	JPMorgan Downgrades P10 to Neutral From Overweight, Cuts Price Target to $9.50 From $15.50	MT
01/03/24	Keefe Bruyette & Woods Downgrades P10 to Market Perform From Outperform, Adjusts Price Target to $10 From $12	MT
11/01/24	Oppenheimer Adjusts P10 Price Target to $17 From $15, Maintains Outperform Rating	MT
10/11/23	Stephens Trims Price Target on P10 to $15 From $16, Keeps Overweight Rating	MT
20/10/23	UBS Adjusts P10 Price Target to $13.50 From $14.50, Maintains Buy Rating	MT
18/10/23	Morgan Stanley Adjusts Price Target on P10 to $13 From $14, Maintains Overweight Rating	MT
09/10/23	Oppenheimer Trims P10's Price Target to $15 From $16, Keeps Outperform Rating	MT
16/08/23	UBS Adjusts P10 Price Target to $14.50 From $12, Maintains Buy Rating	MT

More recommendations

Wealth Management

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	RIDGEPOST CAPITAL, INC					+30.37%
	BLACKROCK, INC.					+16.06%
	UBS GROUP AG					+12.65%
	BANK OF NEW YORK MELLON CORPORATION (THE)					+10.99%
	BLACKSTONE INC.					+15.89%
	BROOKFIELD CORPORATION					+15.86%
	KKR & CO. INC.					+22.66%
	BROOKFIELD ASSET MANAGEMENT LTD.					+2.57%
	APOLLO GLOBAL MANAGEMENT, INC.					+26.12%
	STATE STREET CORPORATION					+16.58%
	Average					+16.98%
	Weighted average by Cap.					+15.11%